Cyrium Technologies Incorporated – Alternative Energy – Deals and Alliances Profile —- Aarkstore Enterprise

Summary

Cyrium Technologies Incorporated – Alternative Energy – Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Cyrium Technologies Incorporated (Cyrium Technologies) is one of the leading manufacturer of solar cells. The company is principally engaged in design and development of high efficiency photovoltaic cells by using breakthrough semiconductor nanotechnology. Cyrium Technologies offers simple, reliable, efficient and cost effective solution with the help of concentrated photovoltaic system for energy generation in the solar industry. The company provides solar cells for concentrated photovoltaic applications and for the space and terrestrial markets. Cyrium Technologies also caters to solar cell and satellite manufacturers for the product and business needs.

And More inside the report…

Recent Developments

Dec 15, 2009: Cyrium Introduces QDEC For Land-Based, Commercial Solar Applications
Aug 31, 2009: Cyrium Technologies Appoints Harry Rozakis As CEO And President
May 21, 2009: Cyrium Technologies’ Solar Cell Offers 40% Efficiency

Scope

– Provides key company information for business intelligence needs
– Gives information on the company’s major recent financial deals including mergers & acquisitions, financing of new and acquired assets, PE/VC deals, equity offerings, debt offerings and partnerships.
– Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Steps

– A quick “one-stop-shop” to understand the company.
– Support sales activities by understanding your customers’ businesses.
– Qualify prospective partners and suppliers.
– Understand and respond to your competitors’ business structure, strategy and prospects through.
– Understanding the key deals which have shaped the company.

For more information, please visit :

http://www.aarkstore.com/reports/Cyrium-Technologies-Incorporated-Alternative-Energy-Deals-and-Alliances-Profile-21438.html

OR

http://www.aarkstore.com/showreport.asp?reportid=21438

Global Nanotechnology Market for Energy Storage – Analysis and Forecasts to 2015—Aarkstore Enterprise Market Research Aggregation

Summary

New report, Global Nanotechnology Markets for Energy Storage – Analysis and Forecasts to 2015″, provides key data, information and analysis on the market opportunities in the nanotechnology enabled energy storage market. The report provides key market trends and competitive landscape analysis for the market. The research discusses market dynamics in detail by providing analytical content on the key challenges for the commercialization of nanotechnology. The report’s coverage of the nanotechnology enabled energy storage market is comprehensive with dedicated sections on the state of research, patent analysis, and key supplier profiles.

Scope

– Qualitative analysis of market drivers, restraints, future outlook, and challenges for the global nano-based energy storage market.
– Comprehensive coverage of R&D initiatives in nanotechnology for energy storage products.
– Competitive landscape section that provides company share information for 2008. Key players covered include Altair Nanotechnologies Inc, Valence Technology Inc., mPhase Technologies Inc., Nanoexa, Inc., and Maxwell Technologies Inc.
– Market sizing (revenue) forecasts for the lithium ion and ultracapacitors market from 2009 to 2015
– Key topics covered include nanotechnology enabled batteries, the ultracapacitor market potential, the state of research, and patent activities analysis.

Reasons to buy

- Gain most up to date information and analysis on the potential opportunities and challenges in the Global Nanotechnology Markets for Energy Efficiency and Energy Storage
- Identify growth segments and opportunities in the Global Nanotechnology Markets for Energy Efficiency and Energy Storage
- Facilitate decision-making based on strong historic and forecast data, deal analysis and recent developments
- Drive business decisions based on the analysis of key players and their market share
- Develop strategies based on the latest operational and regulatory events in the world
- Understand potential market opportunities in various geographies and fine tune your business strategy

For more information, please visit:

http://www.aarkstore.com/reports/Global-Nanotechnology-Market-for-Energy-Storage-Analysis-and-Forecasts-to-2015-40775.html

Or email us at press@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

Follow us on twitter: http://twitter.com/aarkstoredotcom

Contrast Media: A Market Snapshot—-Aarkstore Enterprise Market Research Aggregation

Aarkstore announce a new report  “Contrast Media: A Market Snapshot” through its vast collection of market research report.

Contrast Media: A Market Snapshot

Summary

The global contrast media market was valued at $5.4 billion in 2008, and is expected to grow to $7.9 billion in 2015. The global market will witness a growth at 5% Compounded Annual Growth Rate (CAGR) due to patent expiry of leading contrast agents such as Myoview and Visipaque in 2010-2011, consequent entry of generics, declining reimbursement and adverse clinical studies associated with contrast agents. Key players in the contrast media market are Bracco Imaging, GE Healthcare and Bayer Schering Pharma.

Contrast agents, also known as contrast media, are used during medical imaging examinations to highlight specific parts of the body and enhance their contrast. Contrast agents can help detect diseases earlier and more precisely. Moreover, they can provide relevant diagnostic information that physicians are otherwise frequently unable to obtain without using invasive methods. Thus, they play a crucial part in guiding, monitoring and following up treatment.

Contrast agents can be classified according to the imaging technique in which they are used: X-Ray contrast agents, MRI contrast agents, and ultrasound contrast agents. While X-Ray and MRI agents are mature markets, and patents of market leading agents expiring in the next few years, ultrasound agents present tremendous market opportunities. Ultrasound agents are based on gas microbubble technology and are considered to have low adverse effects as compared to iodine or gadolinium based contrast agents.

Scope

– The study looks at the global contrast media market, both in terms of revenue and geographic segmentation, during 2008-2015.
– It also provides information on the key applications of the contrast media market.
– It discusses the key players in the market, briefing market shares of key players and the recent deals in the contrast media market.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 GlobalData Viewpoint 6
2.1 Summary 6
3 Contrast Media: A Market Snapshot 7
3.1 The Global Contrast Media Market is expected To Value at Approximately $8 Billion in 2015 7
3.2 Contrast Agents Have Applications in Various In-Vivo Diagnostic Imaging Systems 10
3.2.1.1 X-Ray/Computed Tomography (CT) Contrast Media 10
3.2.1.2 MRI Contrast Media 10
3.2.1.3 Ultrasound Contrast Media 11
3.3 Nanotechnology to Drive Innovation in Contrast Media Market 12
3.4 The Key Players in Global Contrast Media Market are Bracco Imaging, GE Healthcare and Bayer Schering Pharma 13
4 Appendix 15
4.1 GlobalData Research Methodology 15
4.2 Secondary Research 16
4.3 Primary Research 17
4.4 Models 17
4.5 Forecasts 18
4.6 Expert Panel Validation 18
4.7 Currency Conversion 19
4.8 Contact Us 20
4.9 Disclaimer 20

1.1 List of Tables
Table 1: Contrast Media Market, Global, Revenue ($ billion), 2008–2015 7
Table 2: Contrast Media Market, Geographic Segmentation, Revenue ($ m), 2008–2015 9
Table 3: USD to Local Currency, Average Exchange Rate 2008 19

1.2 List of Figures
Figure 1: Contrast Media Market, Global, Revenue ($ billion), 2008–2015 7
Figure 2: Contrast Media Market, Geographic Segmentation, Revenue ($ m), 2008–2015 9
Figure 3: Contrast Media Market, Company Shares, 2008–2015 13
Figure 4: GlobalData Methodology 16

Keywords

Medical Devices, Medical Equipment, News Analysis, Viewpoint

For more information, please visit :
http://www.aarkstore.com/reports/Contrast-Media-A-Market-Snapshot-35203.html
Or email us at press@aarkstore.com or call +919272852585

Advanced Storage Battery Market: From Hybrid/electric Vehicles To Cell Phones-Aarkstore Enterprise

Whether it is a battery for the latest laptop, energy storage for a hybrid electric vehicle, or backup power for a remote telecommunications site, everyone wants a battery that has the highest energy density, best safety factor, and longest life in term of discharge cycles and ease of maintenance while still being environmentally friendly. These are the drivers behind rechargeable battery research around the world today. Rechargeable batteries, also known as storage batteries, are a continuing strong market, with worldwide sales of $36 billion in 2008. The rechargeable battery market will rise to $51 billion by 2013.

Lithium-ion is the battery chemistry of choice for future generations of portable electronics and hybrid and plug-in hybrid electric vehicles. In 2008, lithium-ion battery research had more funding than all other battery technologies combined. Nanotechnology and chemistry advances in electrode design are the key research topics that companies are using to push lithium-ion to be the dominant energy storage technology in the future.

The portable rechargeable battery market, of which lithium-ion has a 75% share, is the fastest growing segment of the rechargeable battery market, showing world market growth of 20% in 2008. Nickel-cadmium (Ni-Cd) batteries, still important for power tools and back-up systems, will decline rapidly in market share by 2013 due to stricter environmental controls on cadmium. And Ni-MH will see its market share slowly erode due to increasing lithium-ion market share and new silver-zinc and nickel-zinc rechargeable battery chemistries that are coming to market.

But despite the growing portable rechargeable battery market share, tried and true lead-acid battery technology continues to head rechargeable battery sales with a U.S. rechargeable battery market share of 79% in 2008. Current research using carbon based cathodes means that we will see lead acid batteries hold their traditional stronghold markets of automotive, industrial, and telecommunications backup markets.

Ni-MH hybrid vehicle batteries, which accounted for 1.7% of the world rechargeable battery market in 2008, will grow to hold 4.2% of market share by 2013 and will be shared by Ni-MH and lithium-ion batteries. Large scale batteries, particularly sodium sulfur (NaS), will grow from a $235 million per year market to $900 million a year in 2013 on the growth of increased renewable energy power generation.

There are other possibilities on the energy storage horizon such as ultracapacitors and fuel cells. But the reality of the next five years is that rechargeable batteries will continue to be the energy storage system of choice for portable electronics and power tools, as well expand new markets in motor vehicles and large scale renewable energy systems.

Advanced Rechargeable Battery Market: Emerging Technologies and Trends Worldwide contains comprehensive data on the U.S. and world market for storage batteries, including historical (2002-2008) and forecast (2009-2013) market size data. The report identifies key factors driving battery research, trends affecting the marketplace and market growth, and profiles major marketers and consumer demographics.

For more information please visit:

http://www.aarkstore.com/reports/Advanced-Storage-Battery-Market-from-Hybrid-Electric-Vehicles-to-Cell-Phones-13042.html

PH.NO. 919272852585

Key Players And Innovative Start-Ups In Nutraceuticals: Emerging Strategies In Ingredients, Pharma, Food And Drinks-Aarkstore Enterprise

Pharmaceuticals, on the other hand, are bioactive compounds intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. Pharmaceuticals are most often new chemical entities.

Well known nutraceuticals include essential fatty acids such as omega-3 oils, probiotics, prebiotics, plant sterols, botanicals, superfruit extracts, carotenoid antioxidants and soy protein/isoflavones. Over the past few years, most of these nutraceutical ingredients have made good progress in the marketplace and are now available in a wide range of foods and drinks, as well as supplements. Some have also been developed as pharmaceuticals.

The consumer environment is driving growth in the nutraceuticals market. Over the past decade, consumers have become more concerned for their health and are increasingly inclined to self-medicate. Healthcare providers, too, are keen to shift some of the burden of healthcare costs to individuals and recognize that functional foods may provide alternatives to medications. These factors are reflected in the current market for ingredients in the health and nutrition sector, which was estimated to be worth US$4 billion in 2009.

Key features of this report

• Identify leading companies at the forefront of the nutraceuticals industry who will drive the market for a new generation of “value added” health products.

• Provide case studies of these leading companies in the finished goods (foods and drinks), ingredients and other raw materials, or pharmaceutical sectors.

• Analyze the key trends and issues confronting the different industry sectors at this time.

• Review the backgrounds, discovery strategies and business models of new and innovative entrants to this marketplace.

Scope of this report

• Identify the companies leading the field in the nutraceuticals industry from across a range of different market sectors

• Review their key products and the ways in which these products are being marketed to consumers

• Learn more about the increased efforts of these companies to establish the health benefits of their products in clinical trials

• Identify innovative companies and discover the potential of their various approaches for discovery and marketing novel nutraceuticals

Key Market Issues

• The food market is changing: Over the past decade, consumers have become more concerned for their health and are increasingly inclined to self-medicate. Healthcare providers, too, are keen to shift some of the burden of healthcare costs to individuals and recognize that functional foods may provide alternatives to medications. These factors are reflected in the current market for ingredients in the health and nutrition sector, which was estimated to be worth US$4billion in 2009.
• Nutraceuticals and pharmaceuticals are related in that both are types of compound that demonstrate bioactive properties. Nutraceuticals are substances that are extracted from foods and are used either to fortify other food products in order to enhance their nutritional properties or are taken as dietary supplements in the form of pills, capsules of soft-gels. The clinical evidence behind a nutraceutical products varies widely; some have been tested with pharmaceutical rigor to demonstrate properties beneficial to health, while for other the evidence to support such claims is slim.

Key findings from this report

• New food and drink regulations were introduced in Europe in 2006 and have been generating uncertainty and frustration throughout the industry. The European Food Safety Authority is processing more than 4,000 generic health claims, as well as health claims for emerging and proprietary science or disease risk reduction. The regulator has rejected a large number of the applications reviewed to date (September 2009) and has missed a number of deadlines, suggesting that the overall process may take much longer than expected.

• FDA regulations are generally regarded as less stringent than those in the EU. Nevertheless, they come under criticism for not allowing companies to use in their product labeling relevant data generated in a clinical setting that links the food with a health benefit. Some of the smaller, innovative companies reviewed for this report are developing their business models with this fact in mind.

Key questions answered

• Which companies are the market leaders in the nutraceuticals industry, as identified from a review of finished goods companies, raw materials manufacturers and pharmaceutical companies?

• What are the key products of these companies and how do they exemplify the future direction of the nutraceutical industry?

• How are the market leaders approaching the need for research to back their products with health claims that are understandable by the consumer?
 
 
  Table of Contents : 
Table of Contents
Key Players and Innovative Start-ups in Nutraceuticals: Emerging strategies in ingredients, pharma, food and drinks
Executive summary 10
Defining nutraceuticals 10
Market leaders: food and drinks manufacturers 11
Market leaders: ingredients 12
Market leaders: pharmaceutical companies 13
Developing new ingredients: innovative start-up companies 14
Market drivers and trends 15
Chapter 1 Defining nutraceuticals 18
Summary 18
Introduction 19
Defining nutraceuticals 20
Examples of nutraceuticals 22
Omega-3 oils 24
Probiotics 25
Prebiotics 28
Plant stanols and sterols 29
Superfruits and antioxidants 30
The nutraceuticals market 31
Report outline 34
Chapter 2 Market leaders: Food and drinks companies 38
Summary 38
Introduction 39
Market Leaders: Case studies 40
Case study: Nestlé 40
Case study: Unilever 46
Case study: Groupe Danone 50
Case study: PepsiCo 54
Case study: Coca-Cola 56
Conclusions 58
Chapter 3 Market leaders: Ingredients 62
Summary 62
Introduction 63
Companies with diverse nutraceutical portfolios 64
Case study: DSM Nutritionals 64
Case study: Cognis 68
Case study: Cargill Inc 70
Case study: Ajinomoto 72
Case study: Kerry Group 74
Case study: Glanbia Foods 76
Probiotics 79
Case study: Chr. Hansen 79
Case study: Danisco 82
Prebiotics 85
Case study: BENEO 85
Fats and oils 87
Case study: Ocean Nutrition Canada 88
Agriculture 91
Case study: Dow AgroSciences 92
Case study: Monsanto 93
Case study: DuPont 93
Conclusions 94
Chapter 4 Market Leaders: Pharmaceutical companies 96
Summary 96
Introduction 97
Market leaders: Case studies 99
Case Study: Abbott Nutrition 99
Case study: Bayer Consumer Care 101
Case study: Pfizer 103
Case study: GSK Consumer Healthcare 105
Case study: McNeil Nutritionals 107
Case study: Mead Johnson Nutritionals 108
Discussion 109
Chapter 5 Developing new ingredients: Innovative start-up companies 112
Summary 112
Introduction 113
Case study: Advana Science 115
Case study: WellGen Inc 116
Case study: InterMed Discovery 118
Case study: Provexis 119
Case study: Clasado Ltd 122
Case study: Cambridge Theranostics Ltd 123
Case Study: HerbalScience Group 125
Business models 126
Conclusions 130
Chapter 6 Market drivers and trends 132
Summary 132
Introduction 133
Regulatory considerations 133
Japan 134
United States 135
Europe 137
Intellectual property 140
Development costs 141
Opportunities in the nutraceuticals market 142
Opportunities for medical foods 144
International emerging markets 146
The science driving the future foods market 148
Nutrigenomics and nutrigenetics 148
Epigenetics 148
Nanotechnology 149
Conclusions 149
Chapter 7 Appendix 152
Primary research methodology 152
Acknowledgments 152
Glossary 153
Index 156
Bibliography 158
Endnotes 163

List of Figures
Figure 1.1: Different types of medical food and their uses 22
Figure 1.2: The health and nutrition sector 32
Figure 1.3: Key US consumer health concerns, 2009 33
Figure 1.4: The role of food and pharmaceuticals in the healthcare continuum 34
Figure 1.5: End products for nutraceutical ingredients 35
Figure 2.1: Danone’s sales figures by business line and sales region (2008) 50
Figure 3.1: Technologies for nutraceutical product development at Kerry Group 75
Figure 3.2: Defining Danisco’s Bioactives and Enabler ingredients 82
Figure 5.1: InterMed Discovery’s active ingredient pipeline 118
Figure 5.2: A comparison of research paradigms in the pharmaceutical and nutraceutical industries 127
Figure 5.3: Examples of business models adopted by innovative nutraceutical companies 128
Figure 6.1: Opportunities and threats for the nutraceuticals industry 133
Figure 6.2: Types of EFSA health claims 138
Figure 6.3: Key attributes for product success 143
Figure 6.4: Opportunities for medical foods 145
Figure 6.5: Growth in the number of potential consumers from developing and emerging countries: 2008-2018 147

List of Tables
Table 1.1: Examples of nutraceuticals 23
Table 1.2: Omega-3 and Omega-6 fatty acids and their dietary sources 24
Table 1.3: Examples of common antioxidants present in food 30
Table 2.1: Leading food companies: revenues and product focus 39
Table 2.2: Nestlé sales by product area (CHFm), 2008 40
Table 2.3: Nestlé’s Branded Active Benefits 42
Table 2.4: Examples of brands from Nestlé Nutrition 43
Table 2.5: Functional ingredients included in Danone’s dairy products 51
Table 3.6: Market leaders: Ingredients 63
Table 3.7: Nutraceutical or personalized nutrition companies participated in by DSM Venturing 67
Table 3.8: Examples of ingredients from Danisco 83
Table 4.1: Market Leaders: Pharma 98
Table 4.2: Leading nutraceutical products from Abbott Nutrition 100
Table 4.3: Leading nutraceutical products from Bayer Consumer Care 102
Table 4.4: Leading nutritional products from Pfizer 104
Table 5.1: Innovative companies and start-ups in the nutraceutical sector 114
Table 5.2: Examples of innovative companies exploring novel manufacturing methods 115
Table 5.3: Products or projects in development at Provexis 120
Table 6.1: Health claims meeting significant scientific agreement 137
 
 

For More information please contact :

http://www.aarkstore.com/reports/Key-Players-and-Innovative-Start-Ups-in-Nutraceuticals-Emerging-strategies-in-ingredients-pharma-food-and-drinks-36739.html

Next Page »